CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 7
INTEGRATIVE ONCOLOGY 

Vitamin E

Complementary Therapies, Herbs, and other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | June 18, 2010
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Vitamin E is a fat-soluble vitamin found in green leafy vegetables, whole grains, nuts and seeds, wheat germ, eggs, and in oils derived from soybeans, almonds, safflower, and sunflower. It is also an antioxidant and is said to confer protection against Alzheimer’s, Parkinson’s, cardiovascular disease, arthritis, and cancer.

Although observational data suggest a correlation between high intake of foods rich in vitamin E(Drug information on vitamin e) and lowered risk of cancer, randomized trials using vitamin E supplements failed to validate those findings; some studies suggest that vitamin E supplementation can actually increase all-cause mortality.

In addition, because of its antioxidant property, vitamin E can interfere with the actions of certain chemotherapeutic agents.

Further studies are needed to resolve the uncertainty over vitamin E supplementation in disease prevention. Many studies now show that dietary supplements are not equivalent to foods in efforts to obtain sufficient vitamin levels.

—Barrie Cassileth, PhD

ALSO KNOWN AS: Tocopherol, alpha-tocopherol, dl-tocopherol, tocotrienol.

SUMMARY: Vitamin E is a fat-soluble vitamin found in green leafy vegetables, whole grains, nuts and seeds, wheat germ, eggs, and in oils derived from soybeans, almonds, safflower, and sunflower. It acts as an antioxidant and is purported to help prevent Alzheimer’s disease, Parkinson’s disease, cardiovascular disease, arthritis, and cancer. The supplemental form of vitamin E is available in the form of topical oils and as tablets and capsules.

The hypothesis that vitamin E reduces oxidative stress has prompted research into vitamin E for disease prevention over the last two decades.VitE

Vitamin E supplementation was shown to improve immune response in the elderly, and to slow the progression of Alzheimer’s disease,[1] but was ineffective in arresting the development or progression of early Parkinson’s disease[2] and macular degeneration.[3]

Other studies failed to support benefits of vitamin E in reducing the incidence of acute respiratory tract infections[4] and in lowering the risk of cardiovascular disease; vitamin E actually may increase the risk of stroke.[5]

The role of vitamin E in cancer prevention is ambiguous. Data from observational studies suggest a positive association between consumption of foods high in vitamin E and reduced risk of cancer.[6] Vitamin E supplementation was also effective against hot flashes in breast cancer survivors,[7] and in reducing neurotoxicity in patients treated with cisplatin(Drug information on cisplatin).[8]

However, supplementation with vitamins E, C, and beta carotene did not prevent cancer incidence in randomized clinical trials,[9] nor did it affect cancer mortality.[10]

The large prevention study SELECT (Selenium and Vitamin E Cancer Prevention Trial), based on previous data indicating that selenium(Drug information on selenium) and vitamin E reduced the incidence of prostate cancer, also failed to support their protective effects. The trial was suspended in January 2009, when initial data analysis showed no reduction in the risk of prostate cancer with selenium alone or with vitamin E.[11]

Vitamin E supplementation may also increase the risk of lung cancer[12] and overall mortality.[9]

ADVERSE REACTIONS: Daily supplementation over 400 IU may increase all-cause mortality.[13]

Vitamin E supplementation may increase the risk of hemorrhagic stroke.[5]

Warfarin: It has been reported that vitamin E at doses greater than 400 IU per day may increase the effects of warfarin(Drug information on warfarin), but data are inconsistent.[14,15]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES

1. Engelhart MJ, et al: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223-3229, 2002.

2. Parkinson Study Group: Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 328:176-183, 1993.

3. Taylor HR, et al: Vitamin E supplementation and macular degeneration: Randomised controlled trial. BMJ 325:11-16, 2002.

4. Graat J, et al: Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: A randomized controlled trial. JAMA 288:715-721, 2002.

5. Sesso HD, et al:Vitamins E and C in the prevention of cardiovascular disease in men. The Physicians’ Health Study II Randomized Controlled Trial. JAMA 300:2123-2133, 2008.

6. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035, 1994.

7. Barton D, et al: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495-500, 1998.

8. Pace A, et al: Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial. Neurology 74:762-766, 2010.

9. Bjelakovic G, et al: Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 364:1219-1228, 2004.

10. Lin J, et al: Vitamins C and E and beta carotene supplementation and cancer risk: A randomized controlled trial. J Natl Cancer Inst 101:14-23, 2009.

11. Lippman SM, et al: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39-51, 2009.

12. Slatore CG, et al: Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 177:524-530, 2008.

13. Miller ER, et al: Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37-46, 2005.

14. Corrigan JJ, Marcus FI: Coagulopathy associated with vitamin E ingestion. JAMA 230:1300-1301, 1974.

15. Kim JM, White RH: Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 77:545-546, 1996.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy